These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 32788037

  • 41. Collaborative study for the establishment of erythropoietin BRP batch 3.
    Behr-Gross ME, Daas A, Burns C, Bristow AF.
    Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. New BRP for human plasma calibrated for coagulation factors V, VIII, XI and XIII - collaborative study for establishment of batches 1 and 2.
    Bayer P, Daas A, Milne C.
    Pharmeur Bio Sci Notes; 2011 Nov; 2011(2):16-25. PubMed ID: 22225765
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use.
    Daas A, Bruckner L, Milne C.
    Pharmeur Bio Sci Notes; 2015 Nov; 2015():57-72. PubMed ID: 26830159
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2003 Mar 07; 21(11-12):1165-73. PubMed ID: 12559794
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M, Poirier B, Bornstein N, Marmonier D, El Zaouk A, Fuchs F.
    Biologicals; 2000 Dec 07; 28(4):217-25. PubMed ID: 11237357
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.
    Pediatrics; 1997 Nov 07; 100(5):772-88. PubMed ID: 9346976
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed.
    Sesardic D, Winsnes R, Rigsby P, Gaines-Das R.
    Biologicals; 2001 Jun 07; 29(2):107-22. PubMed ID: 11580215
    [Abstract] [Full Text] [Related]

  • 60. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens.
    Lynn F, Reed GF, Meade BD.
    Clin Diagn Lab Immunol; 1996 Nov 07; 3(6):689-700. PubMed ID: 8914760
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.